Cancer (Oncology)
Breast Cancer in the UK: NICE Approves Ribociclib & A Review of Emerging Modalities
Breast Cancer Care in the UK: Current Modalities and Emerging Advances
Overview of Breast Cancer in the UK
Breast cancer remains a major health challenge in the UK and globally. It is the most common cancer in the UK, accounting for about 15% of all new cancer cas ...
Dr. Anand Mani
30 Jul 2025
Read More
Cancer (Oncology)
Are Breast Cancer Survivors at Higher Risk of Alzheimer’s?
Large Korean cohort finds no increased Alzheimer’s risk among breast cancer survivors—radiotherapy may offer short-term protection.
Introduction
Breast cancer survival rates have soared—yet concerns about long-term cognitive health persis ...
Dr. Anand Mani
08 Jul 2025
Read More
Cancer (Oncology)
NICE Approves AI Tool to Triage Skin Cancer
NICE Approves AI Tool to Triage Skin Cancer
On 1 May 2025, the National Institute for Health and Care Excellence (NICE) issued a major endorsement: the artificial intelligence tool DERM (Deep Ensemble for Recognition of Malignancy), developed by Skin Analytics, has b ...
Dr. Anand Mani
09 Jun 2025
Read More
Cancer (Oncology)
FDA Approves First Oral Drug Combo for Rare Ovarian Cancer
FDA Approves First Oral Drug Combo for Rare Ovarian Cancer: A New Hope for KRAS-Mutated LGSOC Patients
In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Avmapki Fakzynja Co-Pack, a novel oral combination ...
Dr. Anand Mani
15 May 2025
Read More
Cancer (Oncology)
Mayo Clinic's Oncobiome Project Paves the Way for Personalised Cancer Treatment
Unlocking the Gut Microbiome: Mayo Clinic's Oncobiome Project Paves the Way for Personalised Cancer Treatment
In the evolving landscape of oncology, the gut microbiome has emerged as a pivotal player in shaping cancer treatment outcomes. At the forefront of this ...
Dr. Anand Mani
12 May 2025
Read More
Cancer (Oncology)
Three New Cancer Treatments Approved in Europe: A Breakthrough for Patients
Three New Cancer Treatments Approved in Europe: A Comprehensive Overview
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recently approved three innovative cancer treatments: Datroway (datopotamab deruxtecan) for advanc ...
Dr. Anand Mani
02 Feb 2025
Read More
